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Abstract
The non-membrane-damaging cytotoxin which causes dramatic cell rounding of cultured HeLa cells was purified to
homogeneity from a clinical strain (WO5) of non-toxigenic Vibrio cholerae O1 Inaba belonging to the El Tor biotype. The
purified protein has a denatured molecular weight of 35 kDa and a native molecular weight of approximately 37 kDa indicating
the monomeric nature of the protein. The 15 N-terminal amino acid sequence of non-membrane-damaging cytotoxin showed
complete homology to the hemagglutinin protease previously purified and characterized from V. cholerae O1. Purified non-
membrane-damaging cytotoxin from V. cholerae O1 was immunologically and biochemically identical to that previously
purified from V. cholerae O26. Non-membrane-damaging cytotoxin was found to be enterotoxic in rabbit ileal loop assay
inducing accumulation of non-hemorrhagic fluid at 100 Wg and elicited a concentration dependent increase in short circuit
current and tissue conductance of rabbit ileal mucosa mounted on Ussing chambers. A significant serum immunoglobulin G
response against non-membrane-damaging cytotoxin was elicited by patients infected with V. cholerae O139 but not with V.
cholerae O1. These properties make non-membrane-damaging cytotoxin a potential virulence factor of V. cholerae which
should be taken into consideration while making live, attenuated recombinant vaccine strains against cholera. z 1998
Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Cholera, has plagued the world sporadically
through recorded history. The disease has assumed
pandemic proportions on several occasions since
1817 and is still a serious global threat. The O1
and O139 serogroups of Vibrio cholerae are associ-
ated with epidemic cholera while the other se-
rogroups collectively known as non-O1 non-O139
serogroups are associated with sporadic cases of di-
arrhea and are ubiquitously found in the aquatic
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environment [1,2]. Toxigenic strains of V. cholerae
O1 or O139 produce cholera toxin (CT), the activity
of which largely accounts for the secretory diarrhea
that is the hallmark of cholera [3]. A variety of other
putative virulence factors, such as CT-like enterotox-
in [4,5], El Tor hemolysin [6^8], Kanagawa hemoly-
sin [9], shiga-like toxin [10] and heat-stable entero-
toxin [11] are produced by some strains of V.
cholerae, but their role in causing the disease is not
adequately understood.
Despite the wealth of information currently avail-
able on the pathogenesis of V. cholerae, the mecha-
nism by which non-toxigenic (NT) V. cholerae O1
and O139 (NT alludes to the absence of CT genes
and therefore unable to produce CT) or clinical
strains of V. cholerae non-O1 non-O139 devoid of
CT genes are still capable of causing acute secretory
diarrhea clinically indistinguishable from cholera
caused by toxigenic V. cholerae O1 or O139 [12,13],
continues to remain an enigma. The residual diar-
rhea caused by most of the recombinant oral cholera
vaccine strains in human volunteer studies suggests
the presence of as yet unknown toxin(s) capable of
initiating a secretory response.
While investigating the cause of diarrhea due to
NT V. cholerae O1 and O139 and due to clinical
strains of non-O1 non-O139 V. cholerae, and the
residual diarrhea caused by recombinant vaccine
strains of V. cholerae, we found that certain clinical
strains of V. cholerae non-O1 non-O139 produced a
cytotoxic factor which manifested as rapid rounding
of CHO and HeLa cells [12]. In subsequent studies,
this cell-rounding factor was puri¢ed; the activity
was due to a protein which, although 200-times less
potent than CT, induced £uid accumulation in the
rabbit ileal loop [14]. Interestingly, the cell-rounding
factor designated as a non-membrane-damaging cy-
totoxin (NMDCY), was found to be widely distrib-
uted in strains of V. cholerae, irrespective of se-
rogroup and also among strains of V. parahaemo-
lyticus, Aeromonas spp. and Shigella spp. [15].
In the present study, we assessed the importance of
NMDCY in V. cholerae belonging to the O1 se-
rogroup. Our objective was to determine the bio-
chemical and immunological relatedness between
NMDCY puri¢ed from O1 and that previously pu-
ri¢ed from O26 [14], to compare the N-terminal ho-
mology of NMDCY from the O1 strain with known
proteins and ¢nally to con¢rm its enterotoxic prop-
erty using in vivo and in vitro models.
2. Materials and methods
2.1. Bacterial strain and puri¢cation of the
cell-rounding factor
An NT strain of V. cholerae O1 Inaba biotype El
Tor (WO5) isolated during an outbreak and previ-
ously documented to produce a factor which caused
rapid cell rounding of cultured HeLa and CHO cells
was used in this study [13]. NMDCY from WO5 was
puri¢ed using procedures identical to that used for
purifying NMDCY from V. cholerae non-O1 non-
O139 [14]. The native molecular weight was deter-
mined by loading puri¢ed protein (250 Wg) onto a
Sephacryl S200-HR (Sigma) column (1.6U40 cm
Pharmacia) prequilibrated with Tris-HCl bu¡er (pH
7.4) containing 0.15 M NaCl.
2.2. Immunoblot and inhibition of cell rounding by
polyclonal antibody against NMDCY
Antiserum to the puri¢ed NMDCY from strain
WO5 was prepared by immunizing a New Zealand
white rabbit as described previously [14]. Inhibition
of cytotoxic activity determined by the ability of the
antibody to inhibit cell rounding compared with the
control were performed with polyclonal anti-
NMDCY prepared using NMDCY puri¢ed from
V. cholerae O26 [14] and with polyclonal antibody
raised against puri¢ed protein prepared in this study.
Puri¢ed NMDCY from V. cholerae O26 incubated
with immune and preimmune sera were used as pos-
itive and negative controls, respectively.
2.3. Amino acid sequencing
The N-terminal sequencing of the transblotted pu-
ri¢ed protein was performed using a precise Applied
Biosystems 494 protein sequencer running a pulsed
liquid blot sequencing program (Applied Biosystems
Foster City, CA, USA) at the Sequencing Facility of
MacQuarie University, Australia. The homology
search was done with the SWISS PROT and
NBRF-PIR protein sequence libraries.
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2.4. Characterization of puri¢ed NMDCY
The following treatments were performed to fur-
ther de¢ne the protein.
Trypsin treatment and chymotrypsin treatment
were performed as described previously [14].
2.4.1. Hemagglutination (HA) assay
The technique for quantitation of HA was adapted
from Jones et al. [7] using protein solution (100 Wg
ml31) two-fold serially diluted. Puri¢ed HA from a
V. cholerae O2 strain was obtained from K. Baner-
jee, NICED, Calcutta and used as the positive con-
trol [16].
2.4.2. Measurement of protease activity
Casein was chosen as the substrate to assay pro-
teolytic activity. The substrate^enzyme (Azocasein^
protein) mixture was incubated at 37‡C and the re-
action terminated with 10% (w/v) trichloroacetic acid
after 1 h. The precipitated protein was removed by
centrifugation (12 000Ug for 4 min) and the super-
natant transferred to a clean tube containing 525
mM NaOH. Absorbance was measured at 440 nm
using a scanning spectrophotometer (Cecil Instru-
ments Limited, Cambridge, London). Controls were
substrate and bu¡er without enzyme and substrate
and bu¡er with heat-inactivated enzyme. Inhibition
study was performed by incubating the protein with
Tris-HCl bu¡er containing 5 mM EGTA and
EDTA, respectively, prior to the addition of the sub-
strate.
2.5. Rabbit ileal loop assay
The ligated intestinal loop test was performed ac-
cording to the method described by De and Chatter-
jee [17].
2.6. Ussing chambers experiment
The in vitro enterotoxic activity of NMDCY pu-
ri¢ed from V. cholerae O1 was tested by Ussing
chambers experiment [18]. Puri¢ed protein at di¡er-
ent concentrations was added to rabbit ileal tissue
mounted on Ussing chambers. The change in Isc
(the amount of current needed to nullify the poten-
tial di¡erence (PD)) and the PD (the di¡erence in
voltage measured on the mucosal side versus the se-
rosal side of the tissue) were recorded at a 5-min
interval for the ¢rst reading and then at 15-min in-
tervals for up to 110 min [19]. At the end of every
experiment, 200 Wl of 0.5 M glucose was added to the
mucosal side of each chamber. Only those tissues
which showed an increase in Isc in response to glu-
cose indicating tissue viability were included in the
analysis. From these measurements, Gt (tissue con-
ductance) was calculated using Ohm’s law:
Isc = PDUGt.
2.7. Serum antibody response
Acute and convalescent phase sera were collected
from 16 cholera patients infected by either V. cho-
lerae O1 or O139. Immunoglobulin G (IgG) speci¢c
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Table 1
Summary of puri¢cation of NMDCY produced by V. cholerae O1 strain WO5
State Puri¢cation step Volume
(ml)
Protein conc.
(mg ml31)
Total protein
(mg)
Cytotoxic activity
in CRUa
Speci¢c
activity
Recovery Fold
puri¢cation
CRU/ml Total CRU
1 Crude culture supernatant 2000 1.7 3400 1.6U102 3.2U105 0.5U103 100
2 60% Ammonium sulphate
precipitation
80 5 400 1.28U103 1.02U105 0.25U103 31.85 5
3 Anion exchange chroma-
tography with DE52
100 0.3 30 0.64U103 0.64U105 0.021U105 20 42
4 Hydrophobic interactive
chromatography with
phenyl Sepharose CL-4B
4 0.08 0.32 5.12U103 20.48U103 64.0U103 6.4 1280
aCRU, cell-rounding unit, de¢ned as the reciprocal of the highest dilution causing 100% rounding.
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antibody responses in the paired sera were deter-
mined against puri¢ed NMDCY by ELISA in micro-
titration plates (NUNC, Rocksville, Denmark).
Wells were coated with 100 Wl of NMDCY at a
concentration of 1 Wg ml31 in 10 mM PBS and 100
Wl of puri¢ed CT (Sigma) at a concentration of 1 Wg
ml31 in 10 mM PBS separately. Serial doubling di-
lutions of patients’ sera in 1% BSA (100 Wl per well)
were added in triplicate for titration. Binding of the
antibody to the antigen was visualized by adding 100
Wl of O-phenylenediamine dihydrochloride (1 mg
ml31 ; Sigma) as substrate per well. The plates were
read spectrophotometrically at 492 nm using an mi-
croplate reader (Titertek; Flow Laboratories, Helsin-
ki, Finland) and the titer was expressed as the recip-
rocal of the highest dilution of antiserum that
showed an OD492 value of v0.2 in the assay. The
root of the product of the titer showing the highest
dilution was the geometric mean titer (GMT). A 3^4-
fold increase in the antibody titer of the convalescent
serum as compared to that of the acute phase serum
was considered as a positive response.
3. Results and discussion
The NMDCY produced by V. cholerae O1 Inaba
strain (WO5) El Tor biotype was puri¢ed to homo-
geneity by column chromatographies which were
previously established for puri¢cation of NMDCY
from V. cholerae O26 [14] (Table 1). NMDCY
from O1 was found to be heat-labile, sensitive to
trypsin and chymotrypsin and has a denatured mo-
lecular weight of 35 kDa. These properties are iden-
tical to that exhibited by NMDCY puri¢ed from
O26 [14]. The native molecular mass of the puri¢ed
protein determined by gel chromatography was ap-
proximately 37 kDa, suggesting the monomeric na-
ture of the protein.
By Western blot analysis, the antiserum raised
against NMDCY puri¢ed from WO5 recognized
only a single band of 35 kDa and no other secreted
V. cholerae constituent (Fig. 1A). Under the assay
conditions used, a 1:64 dilution of the antiserum
completely neutralized cell-rounding activity of the
supernatant of V. cholerae WO5, whereas preim-
mune serum lacked the neutralizing activity. Further-
more, polyclonal antibody raised against O1
NMDCY also inhibited the cell-rounding activity
of both puri¢ed proteins, from V. cholerae O1 and
O26. Immunologically, NMDCY from V. cholerae
O1 cross-reacted with NMDCY puri¢ed from V.
cholerae O26 as seen by the complete identity of
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Fig. 1. (A) Immunoblot (Western transfer) of V. cholerae O1
NMDCY. Lane 1, molecular mass markers (in kDa); lane 2, pu-
ri¢ed NMDCY reacted with rabbit anti-NMDCY on a nitrocel-
lulose paper; lane 3, total cell protein of strain WO5 reacted
with rabbit anti-NMDCY on a nitrocellulose paper. (B) Immu-
nodi¡usion test of NMDCY of V. cholerae O2 and O26. Well 1,
puri¢ed NMDCY from V. cholerae O1; well 2, V. cholerae O1
NMDCY anti-toxin from an immunized rabbit ; well 3, V. chole-
rae O26 NMDCY antitoxin from an immunized rabbit.
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bands in Ouchterlony’s double di¡usion experiment
(Fig. 1B). The cell-rounding e¡ect exhibited by the
puri¢ed protein was abolished by heating at 65‡C for
10 min. NMDCY, therefore, belongs to the family of
heat-labile toxins. The e¡ect of protein inhibitors,
such as chymotrypsin and trypsin, was also pro-
nounced as incubation with trypsin and chymotryp-
sin for 1 h at 37‡C resulted in the loss of cell-round-
ing activity.
The ¢rst 15 amino-terminal amino acids of the
puri¢ed protein was determined as Ala Gln Ala
Thr Gly Thr Gly Pro Gly Gly Asn Gln Lys Thr
Gly. When compared with the SWISS PROT and
NBRF-PIR protein sequence libraries, the N-termi-
nal 15 amino acid residues of O1, NMDCY showed
complete homology with the N-terminal 15 residues
of the soluble hemagglutinin protease (HA/P) of V.
cholerae O1 ¢rst puri¢ed by Finkelstein and Hanne
[20,21]. However, unlike HA/P, NMDCY puri¢ed
from strain WO5 did not show HA activity at a
concentration of 10 Wg using Balb/c mice and chick-
en erythrocytes, although the protein had signi¢cant
protease activity which was inhibited by metal che-
lators, such as EGTA (5 mM) (Fig. 2). Extensive
dialysis against EDTA (1 mM) and EGTA (1 mM)
resulted in loss of protease activity, although the cell-
rounding activity remained intact.
The secreted HA/P has been characterized as a
zinc-dependent metalloprotease [22] with the ability
to cleave several physiologically important sub-
strates, including mucin, ¢bronectin, and lactoferrin
[23]. It also nicks and activates CT and CT-related
enterotoxins [24]. Besides the protease activity, HA/P
also shows hemagglutinating activity [25,26] on er-
ythrocytes of Balb/c mice, but this activity has not
been consistently reproduced [27,28]. Our study
showed that NMDCY has a protease activity which
is inhibited by metal chelators, but has no hemag-
glutinating activity on Balb/c mice and chicken er-
ythrocytes. The cell-rounding activity of NMDCY
was, however, not inhibited by dialyzing the protein
against EGTA and EDTA, indicating that the cell-
rounding manifestation is not due to the protease
activity. Although these data are very suggestive,
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Fig. 2. Time course of protease activity. Protease activity was de-
termined with azocasein as the substrate. The assay was per-
formed exactly as described in Section 2. Each time point repre-
sents the mean of four determinations.
Table 2
Rabbit ileal loop response of NMDCY puri¢ed from V. cholerae O1 (strain WO5) at di¡erent concentrations
Sample Volume (ml) of £uid accumulated FA ratioa (mean þ S.D.; n = 4)
NMDCY (50 Wg) 3 3
NMDCY (75 Wg) 3.5 0.5 þ 0.02
NMDCY (100 Wg) 6.5 0.928 þ 0.05
Heat-inactivated NMDCY (100 Wg) 3 3
CT (0.5 Wg; positive control)4 7.6 1.085 þ 0.02
PBS (negative control) 3 3
AKI (medium control) 3 3
WO5 (108 cells) 7.1 1.01 þ 0.01
Length of the loop in all experiments was 7 cm. 3, no £uid accumulation.
aFA, £uid accumulation.
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further work needs to be done to determine if
NMDCY and HA/P are indeed the same. There
are a number of proteases now being characterized
from various bacteria that have similar amino acid
sequences and sizes yet turn out to be di¡erent pro-
teins.
The in vivo enterotoxic activity was tested by in-
troducing puri¢ed protein in rabbit ileal loop. At a
protein concentration of 50 Wg per loop and below,
there was no £uid accumulation. At a protein con-
centration of 100 Wg per loop, NMDCY elicited the
accumulation of non-hemorrhagic £uid (Table 2).
The non-toxigenic strain of V. cholerae (WO5)
when introduced in the ileal loop also elicited £uid
accumulation similar to the puri¢ed protein.
The in vivo secretory activity of NMDCY from V.
cholerae O1 was further substantiated by an in vitro
assay. Fig. 3A shows that at all protein concentra-
tions the Isc exhibited a gradual increase in rabbit
ileal mucosa, with the peak being reached at di¡erent
time intervals, depending on the protein concentra-
tion used, indicative of Cl3 secretion. At a protein
concentration of 100 Wg, the peak was attained at
around 50 min which is also the concentration at
which the protein elicited positive ileal loop re-
sponse. A gradual increase in tissue conductance
was also observed with an increase in the time inter-
val which is a direct re£ection of variation in short
circuit current (Fig. 3B). This increase in tissue con-
ductance may be due to alteration in the tight junc-
tion of the ileal tissue, which, in turn, could lead to
£uid accumulation. The addition of glucose at the
end of the experiment showed equivalent responses
in treated and untreated tissues, indicating that glu-
cose-Na active cotransport function was una¡ected
(data not shown). The peak action of NMDCY is
observed around 50^60 min after introduction of the
toxin in Ussing chambers, which suggests that
NMDCY is not a fast-acting toxin like heat-stable
toxins [29], but the action is gradual. One point is
clear that variation in tissue conductance and the
change in short circuit current make NMDCY a
factor similar to zonula occludens toxin (Zot) [30]
of V. cholerae, Clostridium di⁄cile toxin A and re-
sembles accessory cholera enterotoxin (Ace), an en-
terotoxin of V. cholerae which increases short circuit
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Fig. 3. (A) Time course of vIsc of puri¢ed NMDCY from V. cholerae O1; each time point represents the mean of four determinations.
Time 0 is the time at which the puri¢ed NMDCY was introduced into the arms of Lucite chambers. (B) Time course of vGt of puri¢ed
NMDCY from V. cholerae O1; each time point represents the mean of four determinations. Time 0 is the time at which the puri¢ed
NMDCY was introduced into the arms of Lucite chambers.
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current in Ussing chamber and causes £uid secretion
in the ligated rabbit ileal loop [31].
Antitoxin antibody response in acute and conva-
lescent sera of cholera patients was determined
against puri¢ed CT and NMDCY by ELISA. A sig-
ni¢cant (v3-fold) rise in the serum antitoxin anti-
body titer of IgG class was observed in the conva-
lescent phase sera against CT in O1 and O139
infected patients (Table 3). Like CT, a signi¢cant
(v3-fold) rise in the serum antitoxin antibody titer
of IgG class against NMDCY was also observed,
although in only O139-infected patients. Five out
of nine O139-infected patients showed a positive
antibody response against NMDCY with a 3-fold
rise in GMT value. However, no rise in IgG titer
was observed against NMDCY in patients infected
with the O1 serogroup.
The antitoxic IgG antibody response in serum has
previously been shown to be a good correlate of the
gut mucosal immune response to CT in cholera [32].
Although in V. cholerae infection, the organism does
not come in contact with circulating blood, the se-
rum antibody response induced by natural cholera
infection is believed to be, in part, a systemic im-
mune response and, in part, a spillover from the
intestine into the circulation [33]. Our study indi-
cated an interesting ¢nding that NMDCY induces
a strong antitoxin IgG response in patients with V.
cholerae O139 infection, but not with V. cholerae O1
infection. The gradual evolution in the organism
may have led to a stronger e¡ect of NMDCY in
V. cholerae O139 infection, the new etiologic agent
of cholera.
This study, along with an earlier study conducted
in our laboratory [14] for the ¢rst time, demon-
strated the in vivo and in vitro secretogenic nature
of NMDCY. The exact mode of action of the pro-
tein at the concentration of 100 Wg in bringing about
the intestinal ion £ux is still under study. The con-
centration of NMDCY required for demonstration
of enterotoxic activity is quite high and one might
question the physiological relevance of this toxin.
According to the puri¢cation data, the amount of
protein necessary to produce a response in the ileal
loop assay is the equivalent of the activity present in
60 ml of an overnight bacterial culture. A greater
response was seen with only 108 bacterial cells which
would indicate that NMDCY has only a minor con-
tribution to the secretogenic potential of NT V. cho-
lerae. Since a relatively large amount is required to
induce diarrhea, its contribution to the disease de-
pends upon the amount produced by the infecting
strain.
Our previous studies have shown that the amount
of NMDCY produced by strains of V. cholerae vary
widely [15]. Therefore, it appears that strains of V.
cholerae which produce NMDCY above a certain
amount are capable of inducing diarrhea which
might explain why certain strains of V. cholerae
non-O1 non-O139 devoid of CT are associated
with sporadic diarrhea [12,34]. One means to assess
the contribution of NMDCY to the secretory re-
sponse induced by bacterial cells would be to com-
pare a mutant devoid of NMDCY and such a mu-
tant is currently being constructed.
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Table 3
Anti-NMDCY antitoxin IgG in the acute and convalescent sera of cholera patients
Antigen tested Response rate (x/n)a Geometric mean titer
O1 infected serum O139 infected serum O1 infected sera O139 infected sera
Acute Convalescent Acute Convalescent
Puri¢ed NMDCY 0/7 5/9 3200 3200 2300 7100
Cholera toxin 6/7 8/9 1983 6400 2625 8063
aExpressed as the number of sera showing positive response (x) per total number (n) tested. A positive response was considered to be a 3-fold
or more rise in GMT value of convalescent phase serum as compared to that of corresponding acute phase serum.
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